Bio-Sincerity Pharma-Tech Targets $339 Million in Shenzhen IPO-- Hangzhou Bio-Sincerity Pharma-Tech is seeking to raise up to 2.15 billion yuan from its initial public offering on the Shenzhen Stock Exchange. The Chinese drugmaker has priced its offering of...